Journals / MN Oftalmoloji / 2018 / Cilt: 25 - Sayı: 0

Vernal Keratoconjunctivitis

Vernal Keratokonjonktivit

Pages
38–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, we aimed to discuss the treatment and results of “shield ulcer” secondary to vernal keratoconjunctivitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vernal keratoconjunctivitis is a chronic, mostly bilateral allergic inflammation of the ocular surface which occurs with sea- sonal attacks.
📊
Key Findings & Data:The patient who was admitted to our clinic due to the hyperemia, pain and decreased visual acuity in the right eye developed a “shield ulcer” secondary to vernal keratoconjunctivitis in the right and then in the left eye.
💡
Conclusion & Impact:In this case report, we aimed to discuss the treatment and results of “shield ulcer” secondary to vernal keratoconjunctivitis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vernal keratoconjunctivitis is a chronic, mostly bilateral allergic inflammation of the ocular surface which occurs with sea- sonal attacks. Although a spontaneous remission may occur with pubertal termination, it can affect visual acuity due to pseudoptosis and may cause corneal complications. For this reason, it is important to start a topical anti-inflammatory treatment timely and effectively. The patient who was admitted to our clinic due to the hyperemia, pain and decreased visual acuity in the right eye developed a “shield ulcer” secondary to vernal keratoconjunctivitis in the right and then in the left eye. The patient underwent topical anti-inflammatory therapy and amniotic membrane transplantation. The patient with complete healing of the “shield ulcer” is still under treatment with topical cyclosporin-A and is still being followed. In this case report, we aimed to discuss the treatment and results of “shield ulcer” secondary to vernal keratoconjunctivitis.

Özet

Vernal keratokonjonktivit kronik, çoğunlukla bilateral, ataklarla seyreden oküler yüzeyin allerjik inflamasyonudur. Ge nel - likle pubertenin sonlanması ile spontan remisyona giren bir hastalık olmasına rağmen, psödopitoz ve gelişen kornea komp- likasyonları nedeniyle görme keskinliğini etkileyebilmektedir. Bu nedenle topikal anti-inflamatuvar tedavinin etkin ve zama- nında başlanması önemlidir. Kliniğimize sağ gözde kızarıklık, ağrı, görme keskinliğinde azalma şikayeti ile başvuran hasta- nın önce sağ, sonra sol gözünde vernal keratokonjonktivite sekonder “kalkan ülser” gelişti. Hastaya topikal anti-inflamatu- var tedavi başlandı ve amniyon membran transplantasyonu yapıldı.“Kalkan ülseri” düzelen hasta topikal siklosporin-A te- davisi altında ve hala takiptedir. Bu olgu sunumunda vernal keratokonjonktivite sekonder gelişen “kalkan ülser” sonrası uy- gulanan tedavileri ve sonuçlarını tartışmak amaçlanmıştır.

🔖

Cite This Article

ÖZDEMİR, E. Ş., BURCU, A. (2018). Vernal Keratoconjunctivitis. MN Oftalmoloji, Cilt: 25 - Sayı: 0, 38–44. https://ajindex.com/articles/295429

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Solomon A. Corneal complications of vernal kerato- conjunctivitis. Curr Opin Allergy Clin Immunol 2015; 15(5):489-94. Kumar S. Vernal keratoconjunctivitis: a major review. Acta Ophthalmol 2009;87:133-47.
  2. Bonini S, Bonini S, Lambiase A, et al. Vernal kerato- conjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology 2000;107: 1157-211.
  3. Saboo US, Jain M, Reddy JC, Sangwan VS. Demog - raphic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India. Indian J Opht - halmol 2013;61(9):486-9.
  4. Neumann E, Gutmann MJ, Blumenkrantz N, Michaelson IC. A review of fourhundred cases of ver- nal conjunctivitis. Am J Ophthalmol 1959;47:166-72. Burcu A. Nurözler Tabakçı B. Allerjik Kuru Göz. MN Oftalmoloji 2016;23(1):72-82.
  5. Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology Report. Ocul Surf 2017;15(3):539-74. Leonardi A. Lazzarini D. Bortolotti M. Piliego F. Mi de - na E. Fregona I. Corneal confocal microscopy in pa- tients with vernal keratoconjunctivitis. Ophthal mo logy 2012;119:509-15. Metz DP. Bacon AS. Holgate S. Lightman SL. Phe - notypic characterization of T cells infiltrating the con- junctiva in chronic allergic eye disease. J Allergy Clin Immunol 1996;98:686-96. Kamış Ü. Okudan S. Gündüz K. Özkağnıcı A. Çe le bi - oğlu HR. Aslan U. Vernal keratokonjonktivitli olgularda kan eosinofil sayısı ve serum IgE düzeyinin değerlendirilmesi. T Oftalmol Gaz 2002;32:724-32. Addis H. Jeng BH. Vernal keratoconjunctivitis. Clin Opht halmol 2018;12:119-23. Mantelli F. Santos MS. Petitti T. et al. Systematic re- viewand meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis. Br J Ophthalmol 2007;91(12):1656-61. Hida WT. Nogueira DC. Schaefer A. Dantas PEC. Comparative study between 0.025% ketotifen fu- marate and 0.1% olopatadine hydrochloride in thetreatment of vernal keratoconjunctivitis. Arq Bras Oftalmol (Portuguese) 2006;69(6):851-6. Iyer G. Agarwal S. Srinivasan B. Outcomesand Rationale of Excision and Mucous Membrane Graf - ting in Palpebral Vernal Keratoconjunctivitis. Cornea 2018;37(2):172-6. Zanjani H. Aminifard MN. Ghafourian A. et al. Com - parative Evaluation of Tacrolimus Versus Interferon Alpha-2b Eye Drops in theTreatment of Vernal Ke ra - to conjunctivitis: A Randomized, Double-Mas ked Study. Cornea 2017;36(6):675-8. Leonardi A. Management of vernal keratoconjunctivi- tis. Ophthalmol Ther 2013;2(2):73-88. Donnenfeld E. Pflug